Restless legs syndrome - IAFP.com

References
1. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless
legs syndrome and periodic limb movement disorder: an American Academy of
Sleep Medicine review. Sleep. 1999;22:970-999.
2. Chesson AL Jr, Wise M, Davila D, et al. Practice parameters for the treatment of
restless legs syndrome and periodic limb movement disorder: an American
Academy of Sleep Medicine report. Sleep. 1999;22:961-968.
3. National Heart, Lung, and Blood Institute. Restless Legs Syndrome: Detection and
Management in Primary Care. Washington DC: National Institutes of Health; March
2000. NIH Publication No. 00-3788.
4. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria,
special considerations, and epidemiology. A report from the Restless Legs
Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of
Health. Sleep Med. 2003;4:101-119.
5. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless
legs symptoms in adults. Arch Intern Med. 2000;160:2137-2141.
6. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence
and association among Canadians. Sleep. 1994;17:739-743.
7. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among
men aged 18 to 64 years: an association with somatic disease and neuropsychiatric
symptoms. Mov Disord. 2001;16:1159-1163.
8. Ulfberg J, Nystrom B, Carter N, Edling C. Restless legs syndrome among workingaged
women. Eur Neurol. 2001;46:17-19.
9. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk
factors of RLS in an elderly population: the MEMO Study. Memory and morbidity in
Augsburg elderly. Neurology. 2000;54:1064-1068.
10. Allen RP, Earley CJ. Defining the phenotype of the restless legs syndrome (RLS)
using age-of-symptom-onset. Sleep Med. 2000;1:11-19.
11. Allen RP, La Buda MC, Becker P, Earley CJ. Family history study of the restless legs
syndrome. Sleep Med. 2002;3(suppl):S3-S7.
12. Winkelmann J, Muller-Myhsok B, Wittchen HU, et al. Complex segregation analysis
of restless legs syndrome provides evidence for an autosomal dominant mode of
inheritance in early age at onset families. Ann Neurol. 2002;52:297-302.
13. Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant
restless legs syndrome maps on chromosome 14q. Brain. 2003;126(pt 6):1485-1492.
14. Desautels A, Turecki G, Montplaisir J, Sequeria A, Verner A, Rouleau GA.
Identification of a major susceptibility locus for restless legs syndrome on chromosome
12q. Am J Hum Genet. 2001;69:1266-1270.
15. Berger K. Non-opioid analgesics and the risk of restless leg syndrome—a spurious
association? Sleep Med. 2003;4:351-352.
16. Earley CJ, Allen RP, Beard JL, Connor JR. Insight into the pathophysiology of restless
legs syndrome. J Neurosci Res. 2000;62:623-628.
17. Earley CJ, Conner JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in
CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology.
2000;54:1698-1700.
18. Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance
during pregnancy: the role of folate and iron. J Womens Health Gend Based Med.
2001;10:335-341.
19. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage
renal disease. Am J Kidney Dis. 1996;28:372-378.
20. Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology.
1996;47:1435-1441.
21. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless
legs syndrome in dialysis patients after kidney transplantation. Mov Disord.
2002;17:1072-1076.
22. Michaud M, Chabli A, Lavigne G, Montplaisir J. Arm restlessness in patients with
restless legs syndrome. Mov Disord. 2000;15:289-293.
23. Montplaisir J, Lapierre O, Lavigne G. The restless leg syndrome: a condition associated
with periodic or aperiodic slowing of the EEG [in French]. Neurophysiol Clin.
1994;24:131-140.
24. Trenkwalder C, Hening WA, Walters AS, Campbell SS, Rahman K, Chokroverty S.
Circadian rhythm of periodic limb movements and sensory symptoms of restless
legs syndrome. Mov Disord. 1999;14:102-110.
25. Hening WA, Walters AS, Wagner M, et al. Circadian rhythm of motor restlessness
and sensory symptoms in the idiopathic restless legs syndrome. Sleep. 1999;22:901-
912.
26. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs
Syndrome Study Group rating scale for restless legs syndrome. Sleep Med.
2003;4:121-132.
27. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment
of restless legs syndrome: results from the TREAT RLS 1 study, a 12-week, randomised,
placebo controlled study in 10 European countries. J Neurol Neurosurg
Psychiatry. 2004;75:92-97.
28. Earley CJ. Clinical practice: restless legs syndrome. N Engl J Med. 2003;348:2103-
2109.
29. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide
in patients with restless legs syndrome. Neurology. 1999;52:944-950.
30. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome
improved by pramipexole: a double-blind randomized trial. Neurology. 1999;52:938-
943.
31. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa.
Sleep. 1996;19:205-213.
32. Ferini-Strambi L, Oldani A, Castronovo V, Zucconi M. RLS augmentation and
pramipexole long-term treatment. Neurology. 2001;56(suppl 3):A20-A21.
33. Becker PM, Ondo W, Sharon D. Encouraging initial response of restless legs syndrome
to pramipexole. Neurology. 1998;51:1221-1223.
34. Silber MH, Shepard JW Jr, Wisbey JA. Pergolide in the management of restless legs
syndrome: an extended study. Sleep. 1997;20:878-882.
35. Telstad W, Sorensen O, Larsen S, Lillevold PE, Stensrud P, Nyberg-Hansen R.
Treatment of the restless legs syndrome with carbamazepine: a double blind study.
Br Med J (Clin Res Ed). 1984;288:444-446.
36. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G.
Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over
study. Neurology. 2002;59:1573-1579.
37. National Heart, Lung, and Blood Institute Working Group on Restless Legs
Syndrome. Restless legs syndrome; detection and management in primary care. Am
Fam Physician. 2002;62:108-114.
Instructions for Obtaining Credits
Upon completion of this CME activity, participants may
request AMA PRA category 1 credit, AFP Prescribed credit,
or a CME certificate of completion. To receive credit, please
complete both sides of the evaluation/posttest form and
return it to Scienta Healthcare Education ® in the enclosed
envelope.
Scienta Healthcare Education ®
Attention: RLS Posttest Administrator
2511 Old Cornwallis Road, Suite 200
Durham, NC 27713
Commercial Support
Supported by an educational grant from
12